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• Increasing Evidence the Familial Nature for of 
Arrhythmogenlc Right Ventrloular 
Cardlomyopathy 
M,W, Norman, A,S, Cachet, D,E, Ward, A,J, Carom, E, Rowland, 
W,J, McKenna, St, George's Hospital Modlcal School, London, England 
Background: Arrhythmogonlc right ventrlcular cardlomyopathy (ARVC) 1O 
eh~trar.terlsed by flbmlatty myoaardlol replacement, Complications Ineludo 
errhythmta, heart failure and suddon death, A gonetio basis Is rocognised, 
To assess the prevalence of familial ARVO, and the mode of Inheritance we 
~ndortook prospective valuation of ARVC families, 
Method: Evaluation of 05 relatives (eRe range 10.,,47y, mean 29y, 31 
m~le) of ~6 consecutive ARVO probands (ESCtlFSG criteria) In~luded 12 
te~d ECG, signal evcreged ECG, Holler monitoring end ocho¢ardlogrephy, 
Relatives were classified es ARVC; having catalina abnormalities nol meeting 
ARVO dlqnostlo ~riterls; or as normal, 
R~sultl~: In 8/20 (23%) fRmlllea Ihere was ;- 1 case of ARVC, In 7/28 (27%) 
families, relaflvos had ECG abnormnlltleR not me,tinS ARVC dlognoRtiC 
efileda, In total, 10/26 (38%) fRmilles either had ~.1 case ARVC or other 
cardiac abnermNlfles The frequonoy of abnormalities was higher in the ARVC 
families thsn in healthy oontroIR (p ,< 0,05), 8~gmgallen RnRlysla war most 
conel~tent with et~to~omRI dominant lnhafitanee with vad~ble xpression, 
Conclu~ion~: Our survey ~ugg0sIS that familial ARVC is common end 
the freqgen¢]y of EGG abnormalities In rel~tivaR of patients with ARVC is 
Iner~sed, This may represent e~dy ARVC, end euggem e breeder spectrum 
el ill,ease thRn implied by (~urmnt diagnostic ofiterla, 
~ CIInl©al Characteristics of Patients With 
Arrhythmogonlo Right Ventrlculer 
Cardlomyopathy and Left Ventrl©uler Involvement 
0, Corrado, C, Basso, G, Thlsne, W,J, McKennR, A, Nave, G, Fentatne, 
F, Camerinl, Padova and "l~h~, Italy; Lon®R UK: Paris, France 
Background: Arrhylhmogenio right ventdcuIRr cardlomyopathy (ARVC) IRa 
progressive heart musclo disease lhRt with time lards to marc diffuse fight 
ventflcular (RV) changes and left ventricular (LV) Involvement, and it may 
Culminate in heart failure, 
Metho~/s: We studied 42 patients (pts) (~7 males and 15 females, mean 
ROe 29,6 ± 18 ye~)  with clinieRI and/or pathological diagnosis ol ARVC 
either af autopsy (38 pts) or heart t~nsplantotlon (4 pfs), 
Re~u~: Ten pfs had isolated RV Involvement (Oroup A), while the other 
32 (76%) had LV involvement, which was only histological in tS (Group B), 
and histological end macroscoplcal In 17 (group C), 
Group A Group B Group C 
Ago (yr~) 20 t 88 25 t 9,7 1 39 '~ 15"§ 
Famlli~t htsto~, 3 (30%) e (53%) 6 (35%~ 
Dige&sn dill&lion | 9 t ~ I 3.4 t 2.2 93 ~. 7.3 "§ 
Asymptomrqic 7 (?0%) 3 (20%)" 2 (13%)" 
Svncopa 3 (30%) 5 (33%) 3 (18%) 
Inverted T w~ves vt-v4 ~/~ (100%) 11/12 (92%~ 14114 (100%) 
Invetlecl T waves V5, V6 012 1/12 (10%) 9/14 (71%) § 
Ventrtcular arehythmt~s 2 120%) 11 (73%)" t 4 (82%)" 
Hot~'l t~llure 0 O S (47%) "§ 
• = P ~ 0,05 vs group A' § = P. 0,05 v~ group B. 
Conclusions: ARVC pts with LV involvement were significantly older and 
more symptomatic, had a longer dtsoaso duration, morn often had ventricular 
anhythmtas and developed heart failure. 
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~ Mltral Regurgitation in the Presence of Left Atrial 
Thrombus: A Predisposing Factor or Protective 
Mechanism for  Embol ism in Atrial Fibri l lation? 
P,K. Shgh, M.F. Stoddard, B. Dawn, R.A, Longaker. University of Louisville, 
Louisville, KY. USA 
MItrel regurgitation (MR) has bee{~ proposed to decrease the incidence of 
embolism in atrial fibrillation (AF) by reducing stasis in the left atrium. We 
postulated that pre-existing left atrial thrombus fLAT) would be more likely 
to dislodge and embolize in the presence of MR due to increased shearing 
tomes. 
Methods: 281 pts undergoing TEE for predominantly (89%) nonvalvular 
AF were divided Into 4 groups on tho basle of LAT end significant (~ moderate) 
MR: 1) G~ 1 = tAT end MR (n = 22), Grp 2 = LAT end no MR (n=24), G~ 3 
= MR and no tAT (n .  62), and Grp 4 ,~ no tAT or MR (n = ,53), Pts were 
followed for embolism (I,e,, stroke, TIA, or pedpherel embolism) over a mean 
of 31 ~: 21 months (max 85 too), 
Results: Embolism was greater in Grp 2 (60%; 12/24) ve Gq~ I (14%; 
3/22), Grp 3 (15%; 9/62) or Grp 4 (12%; 19/153), Multivedefe logistic re. 
greselon showed that having LAT end no MR (G~ 2) wee the most positive 
predictor of Emb (odds ratio ,, 6,5, p - 00002), Other TEE variables were 
net predictors, Hie was a poRttive predictor (odds ratio w 2,4, p ~ 0,05) but 
heart failure, end use of aspirin or wadafln were nat pre¢!ictore,, Kaplen,Meler 
~nnlysls showed a lower event.free iurvlvel in e~ 2 ve eq~ 1 (p ~ 0..004), 
Grg 3 (p *, O,00O7) and Gq~ 4 (p .  0,0000t), Ewnf.free au~val did net differ 
among Oro,~pR 1, 3 and 4, Age did not dilfer. EF war lower in Grp, v~ Grp a 
(30 ~ 20 ve 51 ~ ~6%, p ~ 0,003), 
tATIMR,~ 1 t ^ T,',~!O ,MR" n 
MR/NO tAT= 3 NO tAT/NO MR == 4
'8i t 
,e I 
,4i 
,21 
00 
• 6 N"ga ~ g all 10o 
MONTHS 
Conctusckns: MR in the presence or absence of LAT protects from em~ 
botism in AF, Pts with LAT and no MR am at highest risk of embolism in 
AF 
~ T h e  Risk of  Life-Long Ant lcoagulat ion Therapy 
I,;an l i e  Signif icantly Loweredby  INR Self Testing 
- 4-Year results of  a Prospect ive Randomized 
Study 
D, Horstkotto 1, C, Piper 1 , M. Wiemed, I, Janda ~, H,D= Schulte 3, 
H.P. Schuithel t, ~Depf. of Mad., Free UnnmrsityBerttn, Germany: 2Dpt. of 
Me¢l,, Hetnrtch.Heine-Universily D~sseldod FFIG. Germany: 3Dpr. of 
Surgeq~, Heinrich.Heine.Universi~/ Dgsseldo~ FRG. Germany 
To evaluate lhe influence of INR ~l l  testing (INR ST) on the ask of thmm- 
betic, thmmboeml~lic (TEl and bleeding complications (eL) following oral 
anticoagulation therapy (OACI, 150 consecutive patients (p) with the indi- 
cation for life long OAC (mechanical valve replacement) were allocatnd to 
2 random arms after a standardized training program in tNR ST using the 
CcaguChek ~' monitor and self adjustment at anticoagulant dosage. 75 p 
(group A) were asked to measure the INR themselves every 3rd day. Antico- 
agulatlon in the remaining 75 p (group B) was managed by home physicians. 
Dudes the education period all 150 p were monitored to a target therapeu. 
tic range of INR 3,5-4,0. P were asked to contact their home physicians 
immediately if the INR was measured ~0.5 below/above the target range 
(INR corridor 3.0-4.5), All p had Outpatient reexaminations every 3 months 
and documented all TE and BL themselves by using special documentation 
cards. 
A (standard management) B (INR ST) 
n Ilost to fonow up) 75 (2) 75 (1) 
follow-up (months) 2456 2508 
n IINR controls) 2,166 27543 
control intervals (days) 20.2 ~ 7 9 3 9 ~: 03 
mean (range) iNR 4 0 L 1.5 (1,4-5,9) 3,7 ¢ 03 (2.3-4.6) 
INR within corridor (%) 3.293 (53.3%) 21 047 (76.4%) 
breedings (%/year) 10.24 4.42 
TE (°,~'year) 3.33 0.92 
severe BL/TE (%/year) 2,62 O.31 
In Conclusion: this r~ndomized study with significantly (p < 0.001) morn 
INR-measu, ements inside the target therapeutic corridor demonstrates a 
significant lower ask for SLATE in p on life-long OAC performing (NR ST, 
